Equal weight loss produced surprisingly unequal metabolic results, with the ketogenic group showing larger reductions in liver fat and stronger improvements in several measures tied to glucose control. The comparison is especially interesting because calories were adjusted so participants across the ketogenic, Mediterranean and low-fat plant-forward groups lost roughly the same amount of weight before being maintained there. That design gives the discussion a more meaningful question than simply asking which diet makes people lose the most weight.
The numerical results are presented clearly and make the differences easy to grasp. Liver fat reportedly fell about 68% with keto compared with roughly 45% in the other two groups, while fasting glucose dropped twice as much in the keto group. The most dramatic figure is the proportion of participants who were no longer classified as prediabetic by the end: 50% on keto, 29% on Mediterranean and 7% on the low-fat diet. Importantly, these findings are presented as results from this particular trial rather than proof that keto universally produces those outcomes.
That restraint becomes especially important once the cardiovascular discussion begins. ApoB decreased in all three groups, with the numerical reduction actually largest on the Mediterranean diet, but the differences between groups were not statistically significant. Rather than declaring a winner from those raw numbers, the presentation explicitly acknowledges that the study cannot establish that one diet lowered ApoB more effectively. The description of the keto menu also adds useful context because it apparently included bacon, sausage and red meat alongside foods such as fish, nuts and seeds.
The analysis gets considerably stronger when it places these findings beside an earlier trial that produced a different result. That 2022 study reportedly compared diets containing 40% and 10% of calories from carbohydrates while matching calories and weight loss, yet found essentially identical liver-fat reductions. Bringing contradictory evidence into the discussion prevents one striking new experiment from being treated as the final word. The admission that both studies have weaknesses also gives the scientific uncertainty appropriate prominence.
Sample size is the biggest reason for caution. Only 44 participants completed the newer trial, leaving roughly 14 people per dietary group, and the participants were specifically obese, prediabetic and affected by fatty liver. Those characteristics make the findings potentially valuable for that population but limit how confidently they can be generalized. The older study had its own substantial dropout problem, so the comparison does not offer a simple stronger-study-versus-weaker-study resolution.
Most valuable is the exploration of protein as a confounding explanation. The keto participants reportedly received 23% of calories from protein compared with 15% in the other groups, meaning carbohydrate intake was not the only major nutritional difference. The discussion connects this to previous trials in which increased protein was associated with greater liver-fat loss despite matched calories, then proposes the logical next experiment: compare keto and Mediterranean diets while matching protein. That turns what could have been a simplistic diet showdown into a much better demonstration of why an intriguing result can generate new questions rather than settle an argument.
Pros
- Clearly explains a calorie- and weight-loss-controlled design that makes the metabolic differences particularly interesting.
- Gives specific results for liver fat, insulin resistance, fasting glucose, prediabetes status and ApoB rather than relying on vague claims of better health.
- Correctly emphasizes that the ApoB differences between groups were not statistically significant.
- Compares the findings with an earlier trial that produced conflicting evidence instead of presenting one small study as definitive.
- Identifies the substantially higher protein intake in the keto group as an important alternative explanation for its apparent advantage.
- Acknowledges the small sample, population specificity and practical importance of long-term dietary adherence.
Cons
- The dramatic framing initially makes the study sound considerably more decisive than the later discussion reveals it to be.
- With only 44 completers divided among three groups, striking percentage differences can appear more conclusive than this preliminary evidence warrants.
- The unequal protein intake makes a clean “keto versus Mediterranean” interpretation difficult because several dietary variables changed simultaneously.
- The discussion proposes plausible explanations involving carbohydrates, insulin and protein, but the trial itself cannot determine which mechanism produced the observed differences.
A striking metabolic result becomes the starting point for a thoughtful examination of why one controlled trial should provoke investigation rather than instant dietary certainty. The small sample and protein imbalance substantially weaken any claim that carbohydrate restriction itself was responsible, but acknowledging those problems makes the analysis far more useful than the sensational framing initially suggests.
